$1.29+0.01 (+0.90%)
Apimeds Pharmaceuticals US, Inc.
Apimeds Pharmaceuticals US, Inc. in the Healthcare sector is trading at $1.29 with a market capitalization of $20M. The stock is currently near its 52-week low of $1.11, remaining 91.0% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. The Whystock Score of 15/100 signals elevated caution as multiple indicators diverge.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company is based in Ras al-Khaimah, the United Arab Emirates. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., I...